<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Category:Companies_based_in_Cambridge> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/foundedBy>	<http://caligraph.org/resource/Medical_Research_Council_(United_Kingdom)> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://www.w3.org/2004/02/skos/core#prefLabel>	"Cambridge Antibody Technology" .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/List_of_pharmaceutical_companies> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/foundedBy>	<http://caligraph.org/resource/David_Chiswell> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Category:Companies_formerly_listed_on_the_Nasdaq> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/foundedBy>	<http://caligraph.org/resource/John_McCafferty> .
<http://caligraph.org/resource/Jane_Osbourn>	<http://caligraph.org/ontology/knownFor>	<http://caligraph.org/resource/Cambridge_Antibody_Technology> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Category:Pharmaceutical_companies_disestablished_in_2007> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Company_based_in_Cambridge> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/location>	<http://caligraph.org/resource/United_Kingdom> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/foundingYear>	"1989" .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://www.w3.org/2000/01/rdf-schema#label>	"Cambridge Antibody Technology" .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Category:Pharmaceutical_companies_of_England> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/keyPerson>	<http://caligraph.org/resource/David_Chiswell> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/service>	<http://caligraph.org/resource/Monoclonal_antibody> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/2002/07/owl#NamedIndividual> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/owningCompany>	<http://caligraph.org/resource/AstraZeneca> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/1989_establishment_in_England> .
<http://caligraph.org/resource/Gregory_Winter>	<http://caligraph.org/ontology/knownFor>	<http://caligraph.org/resource/Cambridge_Antibody_Technology> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Category:1989_establishments_in_England> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/owner>	<http://caligraph.org/resource/AstraZeneca> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/location>	<http://caligraph.org/resource/Granta_Park> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Category:British_companies_established_in_1989> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://www.w3.org/2002/07/owl#sameAs>	<http://dbpedia.org/resource/Cambridge_Antibody_Technology> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://www.w3.org/2004/02/skos/core#altLabel>	"Oxford Glycosciences" .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/equity>	"180.97" .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Pharmaceutical_company_of_England> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/type>	<http://caligraph.org/resource/Public_limited_company> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/location>	<http://caligraph.org/resource/Cambridge> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/country>	<http://caligraph.org/resource/United_Kingdom> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/location>	<http://caligraph.org/resource/Cambridgeshire> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/netIncome>	"25.25" .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/industry>	<http://caligraph.org/resource/Health_care> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/industry>	<http://caligraph.org/resource/Medication> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/foundedBy>	<http://caligraph.org/resource/Gregory_Winter> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/British_company_established_in_1989> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/product>	<http://caligraph.org/resource/Belimumab> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/location>	<http://caligraph.org/resource/England> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/revenue>	"172.5" .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Pharmaceutical_company_disestablished_in_2007> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Company_formerly_listed_on_the_Nasdaq> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/assets>	"215.98" .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/product>	<http://caligraph.org/resource/Adalimumab> .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/operatingIncome>	"147.25" .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/numberOfEmployees>	"300" .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/fate>	"Acquired byAstraZenecain 2006; combined withMedImmunein 2007" .
<http://caligraph.org/resource/Cambridge_Antibody_Technology>	<http://caligraph.org/ontology/successor>	<http://caligraph.org/resource/MedImmune> .